Buy Full Version
"Europe Advanced Wound Care Market"

Let us help you !

Invalid Email.

Please Select Country.

Invalid contact no.

Special Symbols Not Allowed.

Invalid Security Code.

Thank You For Your Interest.

We've Successfully Got Your Message,

Our Executive will get back to you Shortly.

Europe Advanced Wound Care Market Analysis & Forecast 2019-2026

Healthcare	LI_18923	Pages: NA	Dec 2019 \| 2239 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

Advanced wound care consists of products that is used to heal acute or chronic wounds. Advanced wound care products work by regulating adequate oxygen flow and maintaining required temperature around the wound. Further, it provides protection against bacterial & microbial infection, thereby reducing complications.

Increasing cases of patients with diabetes, rise in aging population, and faulty lifestyle are factors that foster growth of the Europe advanced wound care market. However, high cost involved in treatment is a key factor that would restrain the growth of the market across Europe. Rising demand of active wound care products especially in emerging nations are expected to create abundant growth opportunities in this market.

The report segments the Europe advanced wound care market on the basis of application, method, end-user and country. Based on application, this market is segmented into surgical wounds, ulcers, and other wounds, where ulcers are further segmented into diabetic foot ulcers, venous ulcers, pressure ulcers, and arterial ulcers. The method segment includes dressings and grafts, in which dressings segment is further segmented into antimicrobial dressings, foam dressings, gauze, hydrocolloids collagen, film dressings, hydrogels, composites, alginate dressings; and grafts are further segmented into composite skin grafts and biologic grafts. Biologic grafts segments include autografts, allografts and xenografts. On the basis of end-users, the market is segmented into inpatient and outpatient facilities. On the basis of country, the market is segmented into Germany, U.K., Italy, France, Spain, and Rest of Europe (RoE).

Prominent market players operating in this market are Smith and Nephew, PLC. Integra Life Sciences Corporation, Molyncke Health Care, Convatec, Inc., Coloplast Group, Organogenesis, Inc., Medline Industries, Inc., Shire, PLC., Mimedx Group, Inc., Laboratories Urgo and Systagenix.

Key Benefits:

The report provides a comprehensive analysis of current & future market trends and emerging avenues for the growth of this market.
The report offers an overview of changing market dynamics in terms of fast turn-around analysis of stakeholders responses to recent industry policy changes and market trends.
The report offers an insight into competitive landscape in terms of new technological developments, untapped segments, and value chain analysis.
This report entails the detailed quantitative analysis of the current market and estimations through 2014-2020, which assists in identifying the prevailing market opportunities.
Recent developments in government policies on various segments is highlighted along with offering insight into the regulatory framework impacting the market.
The report offers strategic analysis of financial status of key market players, and highlights market share of key vendors.
The report offers the competitive landscape scenario in terms of the strategies adopted by key industry players to consolidate their market presence.

Europe Advanced Wound Care Market Key Segments:

By Application

Surgical Wounds
Ulcers
- Diabetic Foot Ulcers
- Venous Ulcers
- Pressure Ulcers
- Arterial Ulcers
Other Wounds

By Methods

Dressings
- Antimicrobial Dressings
- Foam Dressings
- Gauze
- Hydrocolloids Collagen
- Film Dressings
- Hydrogels
- Composites,
- Alginate Dressings
Grafts
- Composite Skin Grafts
- Biologic Grafts
  - Autografts
  - Allografts
  - Xenografts
By End-Users
- Inpatient
- Outpatient Facilities
By Country
- Germany
- U.K.
- Italy
- France
- Spain
- Rest of Europe (RoE)

Key Company Profile

Smith and Nephew, PLC.
Integra Life Sciences Corporation
Molyncke Health Care
Convatec, Inc.
Coloplast Group
Organogenesis, Inc.
Medline Industries, Inc.
Shire, PLC.
Mimedx Group, Inc.
Laboratories Urgo and Systagenix.

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS

3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities

CHAPTER 4 EUROPE ADVANCED WOUND CARE MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. INFECTION MANAGEMENT

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Silver wound dressings

4.2.4.1. Market size and forecast

4.2.5. Non silver dressings

4.2.5.1. Market size and forecast

4.2.6. Collagen dressings

4.2.6.1. Market size and forecast

4.3. EXUDATE MANAGEMENT

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Hydrocolloids dressings

4.3.4.1. Market size and forecast

4.3.5. Foam dressings

4.3.5.1. Market size and forecast

4.3.6. Alginate dressings

4.3.6.1. Market size and forecast

4.3.7. Hydrogels dressings

4.3.7.1. Market size and forecast

4.4. ACTIVE WOUND CARE

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Skin substitutes

4.4.4.1. Market size and forecast

4.4.5. Growth factors

4.4.5.1. Market size and forecast

4.5. THERAPY DEVICES

4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast
4.5.4. Negative pressure wound therapy

4.5.4.1. Market size and forecast

4.5.5. Oxygen and hyperbaric oxygen equipments

4.5.5.1. Market size and forecast

4.5.6. Electromagnetic therapy devices

4.5.6.1. Market size and forecast

4.5.7. Others

4.5.7.1. Market size and forecast

CHAPTER 5 EUROPE ADVANCED WOUND CARE MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. CHRONIC WOUNDS

5.2.1. Market size and forecast
5.2.2. Pressure ulcers

5.2.2.1. Market size and forecast

5.2.3. Diabetic foot ulcers

5.2.3.1. Market size and forecast

5.2.4. Venous leg ulcers

5.2.4.1. Market size and forecast

5.2.5. Arterial ulcers

5.2.5.1. Market size and forecast

5.3. ACUTE WOUNDS

5.3.1. Market size and forecast
5.3.2. Burns and trauma

5.3.2.1. Market size and forecast

5.3.3. Surgical wounds

5.3.3.1. Market size and forecast

CHAPTER 6 EUROPE ADVANCED WOUND CARE MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS

6.2.1. Market size and forecast

6.3. COMMUNITY HEALTH SERVICE CENTERS

6.3.1. Market size and forecast

CHAPTER 7 EUROPE ADVANCED WOUND CARE MARKET, BY COUNTRY

7.1. OVERVIEW

7.1.1. Key market trends
7.1.2. Key growth factors and opportunities
7.1.3. Market size and forecast

7.1.3.1. Germany market size and forecast
7.1.3.2. France market size and forecast
7.1.3.3. UK market size and forecast
7.1.3.4. Italy market size and forecast
7.1.3.5. Spain market size and forecast
7.1.3.6. Rest of Europe market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1. SMITHS GROUP PLC

8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments

8.2. ALLIQUA BIOMEDICAL, INC.

8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments

8.3. MÖLNLYCKE HEALTH CARE AB

8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments

8.4. INTEGRA LIFESCIENCES HOLDINGS CORPORATION

8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments

8.5. MEDTRONIC PLC

8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments

8.6. ACELITY L.P. INC.

8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments

8.7. CONVATEC HEALTHCARE B S.À.R.L.

8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments

8.8. BSN MEDICAL GMBH

8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments

8.9. 3M COMPANY

8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments

8.10. SRS MEDICAL SYSTEMS, INC.

8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Online Only ~~$2,471~~ $2,224 Data Pack/Excel ~~$2,746~~ $2,471 Single User License ~~$3,840~~ $3,456 Five User License ~~$4,612~~ $4,151 Enterprise User License ~~$6,432~~ $5,789

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com